All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for JAZZ PHARMACEUTICALS INC. · A specialty biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $80,000.00 income · posted Apr 20, 2025

Official filing document

Bills named in this filing 1

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 1

Health Issues

Drug safety, prescription drug abuse, value of prescription drugs; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; S 891 Bipartisan Healthcare Act; HR 1968 Full Year Continuing Appropriations and Extensions Act of 2025, PL 119-4.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.